Glycotest Diagnostics is developing unique and non-invasive blood tests for liver cancers and fibrosis-cirrhosis. Our technology could revolutionize care and treatment for people at risk due to chronic liver disease—both people with viral hepatitis (chronic hepatitis B and C infections) and the rapidly growing population with non-viral hepatitis due to obesity and metabolic disease.
http://www.glycotest.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
1.2 seconds
16x16
32x32
64x64
128x128
Azima, Farad
25 Co●●●●●s Cir
New●●●ork , NY, 10019-1107
US
View this contact
NetScientific Group
Azima, Farad
25 Co●●●●●s Cir
New●●●ork , NY, 10019-1107
US
View this contact
NetScientific Group
Azima, Farad
25 Co●●●●●s Cir
New●●●ork , NY, 10019-1107
US
View this contact
BUY YOUR DOMAIN
12
YEARS
1
MONTHS
2
DAYS
NETWORK SOLUTIONS, LLC.
WHOIS : whois.networksolutions.com
REFERRED : http://networksolutions.com
PAGES IN
THIS WEBSITE
7
SSL
EXTERNAL LINKS
3
SITE IP
160.153.72.35
LOAD TIME
1.244 sec
SCORE
6.2
Glycotest | glycotest.com Reviews
https://glycotest.com
Glycotest Diagnostics is developing unique and non-invasive blood tests for liver cancers and fibrosis-cirrhosis. Our technology could revolutionize care and treatment for people at risk due to chronic liver disease—both people with viral hepatitis (chronic hepatitis B and C infections) and the rapidly growing population with non-viral hepatitis due to obesity and metabolic disease.
glycotest.com
News | glycotest
http://glycotest.com/news
A NetScientific portfolio company. News 22 Jun, 2016. News 22 Jun, 2016. Dr Timothy Block, President, Baruch S. Blumberg Institute and the Hepatitis B Foundation, in a video on the Glycotest Technology. News 22 Jun, 2016. Lawrence Cohen, CEO of Glycotest, presented at Net Scientific’s June 2016 Capital Markets Day. News 08 Jun, 2016. Lawrence Cohen, CEO of Glycotest, will be presenting the company at the New York Venture Summit. On July 21, 2016. News 06 Jan, 2016. News 16 Dec, 2015. News 03 Oct, 2014.
Collaborations
http://glycotest.com/collaborations
A NetScientific portfolio company. Glycotest has entered into a research collaboration with Oncimmune Ltd to explore the combined application of their proprietary tests in the early detection of liver cancer. CALL US : 1 (484) 431-3483.
Management Team
http://glycotest.com/management-team
A NetScientific portfolio company. CALL US : 1 (484) 431-3483.
Investors
http://glycotest.com/investors
A NetScientific portfolio company. Glycotest Ltd is a core subsidiary of NetScientific UK Ltd. NetScientific identifies, develops and commercializes transformative biomedical and healthcare technologies originating from leading universities, teaching hospitals and research institutes, with a focus on United Kingdom and United States. More information about NetScientific’s purpose, core strategy and investment model are available at netscientific.net. CALL US : 1 (484) 431-3483.
Our Company
http://glycotest.com/our-company
A NetScientific portfolio company. Key features of Glycotest’s technology:. Exploits unique disease signal chemistry (glycoprotein fucosylation) present in liver cancers and fibrosis-cirrhosis but absent in healthy individuals. Incorporated into highly promising biomarker panels. Focused on the detection of potentially curable early-stage disease. May outperform currently available serum biomarkers, such as AFP. CALL US : 1 (484) 431-3483.
TOTAL PAGES IN THIS WEBSITE
7
London Web Designers, Small Business Website Managed Services for Nationwide and West London UK
http://www.nottinghill.biz/portfolio.html
Notting Hill Internet Services. Celebrating our 17th year. We are fortunate enough to be situated in the heart of the beautiful. Click to Visit Website. We are fortunate enough to be situated in the heart of the beautiful South Downs National Park with its spectacular and picturesque surroundings which have over the centuries and to this day been a magnet for artists. This wealth of talent has enabled us to present many artworks with a local interest. AVANA Cosmetic and Beauty. Click to Visit Website.
TOTAL LINKS TO THIS WEBSITE
3
GlycoTech - Glycobiology of Selectins, Cancer Diagnostics, Glycoconjugates
GlycoTech Catalog of Reagents and Apparatus. Using native carbohydrate - protein interactions to advance human health. Search GlycoTech Site for Products. 7860 Beechcraft Ave., Gaithersburg, MD 20879. 1-800-Glycotk ( 459-2685 ),. Now accepting online credit card orders.
Glycotechnology Core Resource
For more than 18 years the UCSD Glycotechnology Core has provided specialized technical services necessary for glycan analysis to a community of cross-discliplinary investigators worldwide. As the service unit of the Glycobiology Research and Training Center (GRTC) we remain true to the mission of facilitating and enhancing glycobiology research and training by University of California faculty with the minimum possible paperwork and bureaucracy. Structural analysis of various glyco-lipids.
Resource for Integrated Glycotechnology - at the Complex Carbohydrate Research Center
The University of Georgia. Resource for Integrated Glycotechnology. At the Complex Carbohydrate Research Center. A structural model of chemokine CCL5 oligomerization determined by a combination of NMR, MS, and SAXS approaches provides a framework for prediction of proteoglycan interactions and mechanism for proteoglycan-mediated oligomerization. NMR chemical shift perturbations identify different binding sites for CS and HS on the LINK-TSG6 module. Mass spectrometry sequences full length glycans from the...
㈱グライコテクニカ：糖鎖解析
GlycoStation糖鎖プロファイリングシステムのプロファイラーは、GlycoStation Reader 2200とGlycoLite 2200が今後の主力製品になります。 受託価格 10検体以下=105,000円 税抜き のところを93,500円にサービス。 産総研 成松先生らのグループより、 レクチンマイクロアレイを用いた癌細胞のMUC1 O-型糖鎖構造変化に関する論文. 阪大医 三善先生らのグループより、 すい臓がんとLectin Microarrayに関する論文. 東北大医学部 加藤先生らが、癌で特異的に発現している糖鎖修飾を受けたポドプラニン分子 polylactosamine, 及びsialylated core1を持つ を標的にした抗体を開発しました。 GlycoLite™ 2100: GlycoStation Reader 1200の下位機種がお手頃価格にてまもなくリリースされます。 ScrippsのYu-Chieh Wang, Jeanne Loringらからタンパク質の翻訳後修飾と多能性に関するレビュー論文が出ました。 産総研の浅島先生らの手になる A lectin-based...
Accurate Manufacturing Chemists GLyco Tectol Engine Oil Test
Now test for oil contamination in minutes with. D 2982 Standard Method Test to. Detect glyco-based antifreeze in used lubricating oils. Sensitive to about 100ppm *Patent no. 1018878.
Glycotest
A NetScientific portfolio company. Glycotest Diagnostics is developing unique and non-invasive blood tests for liver cancers and fibrosis-cirrhosis. Our technology could revolutionize care and treatment for people at risk due to chronic liver disease both people with viral hepatitis (chronic hepatitis B and C infections) and the rapidly growing population with non-viral hepatitis due to obesity and metabolic disease. Glycotest HCC Panel Completes Successful Clinical Product Evaluation. Focused on the det...
GlycoThera - Company Profile
Assessment of N- and O-glycosylation. GlycoThera offers contract analytical services for all stages of biotherapeutics life-cycle management - from bench-scale development to large-scale product release and market supply - of recombinant human biopharmaceuticals (biosimilars, follow-on biologics, biobetters and innovative products) such as monoclonal antibodies, cytokines and hormones. Our clients are big BioTech companies worldwide and also start-up companies and medium sized BioTech enterprises. Based ...
GlycoThera - Company Profile
Assessment of N- and O-glycosylation. GlycoThera offers contract analytical services for all stages of biotherapeutics life-cycle management - from bench-scale development to large-scale product release and market supply - of recombinant human biopharmaceuticals (biosimilars, follow-on biologics, biobetters and innovative products) such as monoclonal antibodies, cytokines and hormones. Our clients are big BioTech companies worldwide and also start-up companies and medium sized BioTech enterprises. Based ...
glycotheranostic.com - glycotheranostic Resources and Information.
glycotheranostics.com - glycotheranostics Resources and Information.
Glycotherapeutic
